Cash flow

31/08/20 12:55 augustine - AMRYT PHARMA PLC
For the twelve months ended December 31, 2019, according to the Annual Report, Amrty's net consolidated cash flows due to operating activities were outflows of US$37.5 million (FY2018: outflows US$15.5 million). Net cash flows due to investing activities in 2019 were inflows of US$24.4 million compared to outflows of US$229 thousand in the preceding year. Net cash flows due to financing activities were inflows of US$65.9 million (FY2018: inflows US$3.3 million). Total cash and cash equivalents at year-end were US$67.2 million (FY2018: US$11.2 million). 
New Account Current Assets created.
New Account Property Plant And Equipment created.
New Account Intangible Assets created.
New Account Goodwill created.
New Account Other Assets created.
New Account Common Stock created.
New Account Capital Surplus created.
New Account Treasury Stock created.
New Account Retained Earnings created.
New Account Other Stockholders' Equity created.
New Account Long Term Debt created.
New Account Deferred Long Term Liability Charges created.
New Account Other Liabilities created.
New Account Current Liabilities created.
New balance date 31/12/18 has been added.
The currency for balance date 31/12/19 has changed from EUR to USD.
New balance date 31/12/17 has been added.
New balance date 31/12/16 has been added.
New balance date 31/12/15 has been added.